Sea Crest Wealth Management, LLC Ionis Pharmaceuticals Inc Transaction History

Sea Crest Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$62.09 - $86.14 $40,544 - $56,249	-653 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$43.37 - $59.54 $63,276 - $86,868	-1,459 Reduced 69.08%	653 $35,000
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $1,972 - $2,470	46 Added 2.23%	2,112 $109,000
Q2 2018 Aug 03, 2018	BUY	$40.53 - $50.7 $5,998 - $7,503	148 Added 7.72%	2,066 $86,000
Q1 2018 Apr 20, 2018	BUY	$44.08 - $55.05 $10,931 - $13,652	248 Added 14.85%	1,918 $85,000
Q4 2017 Feb 02, 2018	BUY	$50.3 - $64.39 $84,001 - $107,531	1,670	1,670 $84,000

407

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.53B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.